| Fahrmann, Johannes F |
University Of Tx Md Anderson Can Ctr
United States |
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer |
5U01CA282216-03 |
|
Claire Zhu, Ph.D. |
| Ji, Hanlee P |
Stanford University
United States |
Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection |
5U01CA282212-02 |
|
Claire Zhu, Ph.D. |
| Anderson, Karen Sue |
Arizona State University-Tempe Campus
United States |
Southwest EDRN Clinical Validation Center for Head and Neck Cancer |
5U01CA281660-03 |
|
Wendy Wang, Ph.D., M.Sc. |
| Livneh, Zvi |
Weizmann Institute Of Science
United States |
Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort |
5U01CA279001-03 |
|
Claire Zhu, Ph.D. |
| Sears, Rosalie C |
Oregon Health & Science University
United States |
Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs |
5U01CA278923-03 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions |
5U01CA274514-03 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Velculescu, Victor E. |
Johns Hopkins University
United States |
DNA evaluation of fragments for early interception (DELFI) of Lung cancer |
5U01CA271896-03 |
|
Guillermo Marquez, Ph.D. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Clinical Validation Center for Hepatocellular Carcinoma |
5U01CA271887-04 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Schoen, Robert E. |
University Of Pittsburgh At Pittsburgh
United States |
Blood-Based Testing for Advanced Adenoma |
5U01CA271884-04 |
|
Matthew Young, Ph.D. |
| Markowitz, Sanford D. |
Case Western Reserve University
United States |
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation |
5U01CA271867-04 |
|
Matthew Young, Ph.D. |
